When the GTM Isn’t Working, Stopping Is the Strategic Move
A cleantech company had been executing hard, in the wrong direction. Before more capital was committed, everything needed to be reset on assumptions that actually reflected how buyers decide.
A cleantech company had been executing hard, but in the wrong direction. The GTM approach had been built on assumptions that didn't reflect how buyers actually made decisions. Before more capital was committed, everything needed to be reset.
When execution misalignment has already consumed capital, the most valuable intervention is diagnostic before it is prescriptive. Diagnose, Define, and Design mapped where Market assumptions had broken down and where the Business architecture was misaligned. The Alignment System rebuilt the strategic foundation before further resources were committed.
When execution misalignment has already consumed capital, the most valuable intervention is diagnostic before it is prescriptive. Diagnose, Define, and Design were activated, mapping where the Market assumptions had broken down, where the Business architecture was misaligned with stage reality, and where the People layer was operating without clear direction. The 360° Approach applied Detect and Direct disciplines to surface root cause, not symptom. The Alignment System rebuilt the strategic foundation before further resources were committed, restoring leadership confidence in the direction, not just the plan.
The company had been operating with a GTM strategy built on assumptions about buyer behaviour that had never been properly tested. In cleantech B2B, assuming policy-driven demand translates into real purchasing decisions on any particular timeline is a common, costly mistake.
The team was executing: meetings held, proposals sent, pipeline built. But conversion wasn't following. The organisation was accumulating execution fatigue without commercial progress.
blacalp was brought in not to add more execution effort, but to stop, diagnose, and reset the GTM approach on what buyers were actually doing.
The company had been operating with a GTM strategy built on a set of assumptions about buyer behaviour that had never been properly tested. In cleantech B2B markets in particular, the assumption that policy-driven demand will translate into real purchasing decisions, on any particular timeline, is a common and costly mistake.
The team was executing. Meetings were being held, proposals were being sent, pipeline was being built. But conversion was not following. The market was not responding the way the strategy had assumed it would, and the organisation was accumulating execution fatigue without accumulating commercial progress.
blacalp was brought in not to add more execution effort, but to stop, diagnose, and reset: rebuilding the GTM approach on the basis of what buyers were actually doing, not what the company had assumed they would do.
The company stopped burning capital on the wrong path, and rebuilt the GTM foundation that made the right path visible, credible, and executable.
The company stopped burning capital on the wrong path, and rebuilt the GTM foundation that made the right path visible, credible, and executable.
What This Case Reflects
Execution momentum is not the same as commercial progress. When the two diverge, the instinct to do more is almost always wrong.
What This Case Reflects
Execution momentum is not the same as commercial progress. When the two diverge, the instinct to do more is almost always wrong. The ability to stop, diagnose, and rebuild is what separates a recoverable misalignment from an expensive one.
If you're executing hard without seeing the commercial results that should follow, let's find out why before more capital goes in the same direction. No pitch. No deck. Just clarity.